首页> 外文期刊>Palliative medicine >Issues and needs in end-of-life decision making: An international modified Delphi study
【24h】

Issues and needs in end-of-life decision making: An international modified Delphi study

机译:生命周期决策中的问题和需求:国际修改的Delphi研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: end-of-life decision making is an important aspect of end-of-life care that can have a significant impact on the process of dying and patients' comfort in the last days of life. Aim: the aim of our study was to identify issues and considerations in end-of-life decision making, and needs for more evidence among palliative care experts, across countries and professions. Participants: 90 palliative care experts from nine countries participated in a modified Delphi study. Participants were asked to identify important issues and considerations in end-of-life decision making and to rate the need for more evidence. Results: experts mentioned 219 issues in end-of-life decision making related to the medical domain, 122 issues related to the patient wishes and 92 related to relatives' wishes, regardless of profession or country (p > 0.05). In accordance, more than 90% of the experts rated the comfort and wishes of the patient and the potential futility of treatment as important considerations in end-of-life decision making, although some variation was present. When asked about issues that are in need of more evidence, 87% mentioned appropriate indications for using sedatives and effects of artificial hydration at the end of life. A total of 83% mentioned adequate communication approaches. Conclusions: palliative care experts from different professions in different countries encounter similar issues in end-of-life decision making. Adequate communication about these issues is universally experienced as a challenge, which might benefit from increased knowledge. This shared experience enables and emphasizes the need for more international research.
机译:背景:临终决策是临终护理的重要方面,会对生命的最后阶段的死亡过程和患者的舒适度产生重大影响。目的:我们研究的目的是确定临终决策中的问题和考虑因素,以及各国和各行业的姑息治疗专家需要更多证据的需求。参与者:来自9个国家的90位姑息治疗专家参加了改良的Delphi研究。要求参与者确定生命周期决策中的重要问题和考虑因素,并评估是否需要更多证据。结果:专家提到与医学领域有关的寿命终了决策中的219个问题,与患者意愿有关的122个问题以及与亲属意愿有关的92个问题,而与职业或国家无关(p> 0.05)。因此,尽管存在一些差异,但超过90%的专家将患者的舒适感和愿望以及潜在的治疗无效性视为生命周期决策中的重要考虑因素。当被问及需要更多证据的问题时,有87%的人提到了使用镇静剂的适当适应症以及生命后期人工补水的作用。共有83%的人提到适当的沟通方式。结论:来自不同国家的不同专业的姑息治疗专家在生命周期决策中遇到类似的问题。关于这些问题的充分交流被普遍认为是一项挑战,这可能会受益于知识的增长。这种共同的经验使并强调需要进行更多的国际研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号